Get started
Author

Rohit Verma

ORCID: 0009-0009-6699-1285
Observed ORCID: 0009-0009-6699-1285
OpenAlex ID: A5065106738
N6-Methyladenosine Modification Controls Circular RNA Immunity
2019 · Y. Grace Chen, Robert Chen, et al. · Molecular Cell · 570
PDF
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine
2022 · Chunfeng Li, Audrey Lee, et al. · Nature Immunology · 496
Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity
2020 · Gillie A. Roth, Emily C. Gale, et al. · ACS Central Science · 199
A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2
2023 · Qian Yin, Wei Luo, et al. · Nature Materials · 98
PDF
SREBP signaling is essential for effective B cell responses
2022 · Wei Luo, Julia Z. Adamska, et al. · Nature Immunology · 75
PDF
Batf3 and Id2 Have a Synergistic Effect on Irf8-Directed Classical CD8α+ Dendritic Cell Development
2013 · Hemant Jaiswal, Monika Kaushik, et al. · The Journal of Immunology · 44
CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy
2024 · Ayush Pant, Brandon Hwa-Lin Bergsneider, et al. · OncoImmunology · 32
The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2024 · Ayush Pant, Aanchal Jain, et al. · Cancer Immunology Research · 26
Molecular and biophysical remodeling of the blood–brain barrier in glioblastoma: mechanistic drivers of tumor–neurovascular crosstalk
2025 · Matthew Abikenari, Matthew Adam Sjoholm, et al. · Frontiers in Physics · 18
PDF
Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2
2023 · Julia Z. Adamska, Rohit Verma, et al. · Cell Reports · 9
PDF
Cutting Edge: ACVRL1 Signaling Augments CD8α+ Dendritic Cell Development
2016 · Rohit Verma, Hemant Jaiswal, et al. · The Journal of Immunology · 8
Nexus of IDO1/Kynurenine Pathway to T-Cell Exhaustion: Hypoxia-Induced Tryptophan Metabolism in Glioblastoma
2026 · Matthew Abikenari, George Nageeb, et al. · Metabolites · 7
PDF
Adaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron–glioma interactions, and tumor microenvironment modulation
2025 · Justin Liu, Joseph H. Ha, et al. · Journal of Neuro-Oncology · 7
PDF
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial
2026 · Michael Lim, Xiaobu Ye, et al. · Nature Medicine · 3
PDF
TMIC-43. Tumor-Associated Neutrophils: A Double-Edged Sword in Glioblastoma Progression
2025 · Matthew Abikenari, John Choi, et al. · Neuro-Oncology · 3
PDF
Kinetic control of macrophage death by PTM-turnover crosstalk in infection and inflammation
2026 · Sandhini Saha, Rohit Verma, et al. · Cell chemical biology · 1
TREM1-PET imaging maps whole-body innate immune responses in a mouse model of metastatic melanoma
2026 · Irene N. Falk, Aisling M. Chaney, et al. · Scientific Reports · 1
PDF
Data from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2024 · Ayush Pant, Aanchal Jain, et al. · 1
Tmic-32. Infigratinib Inhibition of the Thbs1 Pathway in Melanoma Brain Metastasis
2024 · Andrew Tran, John Choi, et al. · Neuro-Oncology · 1
PDF
ICOS‐ImmunoPET Monitors T Cell Activation After Combination Immune Checkpoint Blockade in a Mouse Model of Melanoma Brain Metastasis (Adv. Sci. 56/2026)
2026 · Renesmee C. Kuo, Rohit Verma, et al. · Advanced Science
ICOS‐ImmunoPET Monitors T Cell Activation After Combination Immune Checkpoint Blockade in a Mouse Model of Melanoma Brain Metastasis
2026 · Renesmee C. Kuo, Rohit Verma, et al. · Advanced Science
Figure S2 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2026 · Ayush Pant, Aanchal Jain, et al.
Figure S3 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2026 · Ayush Pant, Aanchal Jain, et al.
Figure S4 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2026 · Ayush Pant, Aanchal Jain, et al.
Figure S6 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors
2026 · Ayush Pant, Aanchal Jain, et al.
Works count: 19
Citation count: 49
H-index: 3
I10-index: 2
Year
Topic
Type